Horizon and Boehringer Ingelheim Enter Oncology Research Service Collaboration

News   Apr 23, 2013

 
Horizon and Boehringer Ingelheim Enter Oncology Research Service Collaboration
 
 
 

RELATED ARTICLES

XenoGesis and Juniper Pharma Services Strengthen Alliance

News

Campanies extend strategic alliance in early drug development services.

READ MORE

Study of What Makes Cells Resistant to Radiation Could Improve Cancer Treatments

News

Electron paramagnetic resonance spectroscopy has shown that the same molecular structures provide resistance to the harmful effects of ionizing radiation for every type of living cell found on Earth, from microorganisms to human cells.

READ MORE

Overexpression of a Cell-cycle Activator Gene Enhances Repair of Dead Heart Muscle

News

Biomedical engineers report a significant advance in efforts to repair a damaged heart after a heart attack, using grafted heart-muscle cells to create a repair patch.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE